Cite
The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma.
MLA
Shi, Cunzhen, et al. “The Proto-Oncogene Mer Tyrosine Kinase Is a Novel Therapeutic Target in Mantle Cell Lymphoma.” Journal of Hematology & Oncology, vol. 11, Mar. 2018, p. 1. EBSCOhost, https://doi.org/10.1186/s13045-018-0584-6.
APA
Shi, C., Li, X., Wang, X., Ding, N., Ping, L., Shi, Y., Mi, L., Lai, Y., Song, Y., & Zhu, J. (2018). The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma. Journal of Hematology & Oncology, 11, 1. https://doi.org/10.1186/s13045-018-0584-6
Chicago
Shi, Cunzhen, Xiangqun Li, Xiaogan Wang, Ning Ding, Lingyan Ping, Yunfei Shi, Lan Mi, Yumei Lai, Yuqin Song, and Jun Zhu. 2018. “The Proto-Oncogene Mer Tyrosine Kinase Is a Novel Therapeutic Target in Mantle Cell Lymphoma.” Journal of Hematology & Oncology 11 (March): 1. doi:10.1186/s13045-018-0584-6.